Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Takeda Pharmaceutical Co Ltd ADR Share Price

TAK

NYQ

$18.54

+$0.28

(1.53%)

Industry: Pharmaceuticals Sector: Health Care

Takeda Pharmaceutical Co Ltd ADR Analyst Forecast

Overview Returns Financials Ratios News FAQs

Takeda Pharmaceutical Co Ltd ADR Share Price Chart

Takeda Pharmaceutical Co Ltd ADR Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$57.69B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

79.3913

Volume

This is the total number of shares traded during the most recent trading day.

3.11M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

3.58%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.08

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$12.99 L

$18.5 H

$18.54

About Takeda Pharmaceutical Co Ltd ADR, Common Stock

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba Fiber, Recombinate, Hemofil, Immunate, Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-licensing agreements with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaborations with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Institute, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, and Teva Pharmaceutical Industries; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei, Zedira/Dr. Falk Pharma, Exelixi GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, KM Biologics, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics. The company was founded in 1781 and is headquartered in Tokyo, Japan. more

Industry: PharmaceuticalsSector: Health Care

Takeda Pharmaceutical Co Ltd ADR Stock Returns

Time Frame	TAK	Sector	S&P500
1-Week Return	1.42%	0.72%	-1.31%
1-Month Return	14.8%	1.27%	0.78%
3-Month Return	31.77%	3.13%	3.46%
6-Month Return	22.3%	15.81%	6.19%
1-Year Return	33.38%	8.89%	11.68%
3-Year Return	16.68%	20.79%	71.21%
5-Year Return	6.12%	35.89%	74.81%
10-Year Return	-22.3%	138.44%	256.59%

Time Frame	TAK	Sector	S&P500
1-Week Return	108.59%	45.37%	-49.72%
1-Month Return	436.16%	16.60%	9.91%
3-Month Return	206.14%	13.31%	14.79%
6-Month Return	50.41%	34.67%	12.95%
1-Year Return	33.38%	8.89%	11.68%
3-Year Return	5.28%	6.50%	19.63%
5-Year Return	1.20%	6.33%	11.82%
10-Year Return	-2.49%	9.08%	13.56%

Takeda Pharmaceutical Co Ltd ADR Financials

	Mar '21	Mar '22	Mar '23	Mar '24	Mar '25	5YR TREND
Total Revenue	3.20T	3.57T	4.03T	4.26T	4.58T	[{"date":"2021-03-31","value":69.8,"profit":true},{"date":"2022-03-31","value":77.9,"profit":true},{"date":"2023-03-31","value":87.91,"profit":true},{"date":"2024-03-31","value":93.06,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Cost of Revenue	994.31B	1.11T	1.24T	1.43T	1.58T	[{"date":"2021-03-31","value":62.92,"profit":true},{"date":"2022-03-31","value":70.04,"profit":true},{"date":"2023-03-31","value":78.73,"profit":true},{"date":"2024-03-31","value":90.59,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Gross Profit	2.20T	2.46T	2.78T	2.83T	3.00T	[{"date":"2021-03-31","value":73.42,"profit":true},{"date":"2022-03-31","value":82.04,"profit":true},{"date":"2023-03-31","value":92.74,"profit":true},{"date":"2024-03-31","value":94.37,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Gross Margin	68.91%	68.99%	69.11%	66.43%	65.51%	[{"date":"2021-03-31","value":99.71,"profit":true},{"date":"2022-03-31","value":99.82,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":96.12,"profit":true},{"date":"2025-03-31","value":94.79,"profit":true}]

Operating Expenses	1.69T	2.00T	2.29T	2.62T	2.66T	[{"date":"2021-03-31","value":63.72,"profit":true},{"date":"2022-03-31","value":75.27,"profit":true},{"date":"2023-03-31","value":86.24,"profit":true},{"date":"2024-03-31","value":98.47,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Operating Income	509.27B	460.84B	490.50B	214.07B	342.59B	[{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":90.49,"profit":true},{"date":"2023-03-31","value":96.32,"profit":true},{"date":"2024-03-31","value":42.04,"profit":true},{"date":"2025-03-31","value":67.27,"profit":true}]
Total Non-Operating Income/Expense	(286.14B)	(301.18B)	(222.20B)	(301.75B)	(328.06B)	[{"date":"2021-03-31","value":-28614400000000,"profit":false},{"date":"2022-03-31","value":-30118000000000,"profit":false},{"date":"2023-03-31","value":-22220000000000,"profit":false},{"date":"2024-03-31","value":-30174700000000,"profit":false},{"date":"2025-03-31","value":-32805600000000,"profit":false}]
Pre-Tax Income	366.24B	302.57B	375.09B	52.79B	175.08B	[{"date":"2021-03-31","value":97.64,"profit":true},{"date":"2022-03-31","value":80.67,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":14.07,"profit":true},{"date":"2025-03-31","value":46.68,"profit":true}]
Income Taxes	(9.94B)	72.41B	58.05B	(91.41B)	66.94B	[{"date":"2021-03-31","value":-13.72,"profit":false},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":80.18,"profit":true},{"date":"2024-03-31","value":-126.24,"profit":false},{"date":"2025-03-31","value":92.45,"profit":true}]
Income After Taxes	376.17B	230.17B	317.04B	144.20B	108.14B	[{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":61.19,"profit":true},{"date":"2023-03-31","value":84.28,"profit":true},{"date":"2024-03-31","value":38.33,"profit":true},{"date":"2025-03-31","value":28.75,"profit":true}]

Income From Continuous Operations	376.17B	230.17B	317.04B	144.20B	108.14B	[{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":61.19,"profit":true},{"date":"2023-03-31","value":84.28,"profit":true},{"date":"2024-03-31","value":38.33,"profit":true},{"date":"2025-03-31","value":28.75,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Net Income	376.00B	230.06B	317.02B	144.07B	107.93B	[{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":61.19,"profit":true},{"date":"2023-03-31","value":84.31,"profit":true},{"date":"2024-03-31","value":38.32,"profit":true},{"date":"2025-03-31","value":28.7,"profit":true}]

EPS (Diluted)	120.59	59.00	54.37	47.04	29.08	[{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":48.93,"profit":true},{"date":"2023-03-31","value":45.08,"profit":true},{"date":"2024-03-31","value":39.01,"profit":true},{"date":"2025-03-31","value":24.12,"profit":true}]

	Mar '21	Mar '22	Mar '23	Mar '24	Mar '25	5YR TREND
Total Revenue	-	11.61%	12.85%	5.87%	7.45%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":90.36,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":45.67,"profit":true},{"date":"2025-03-31","value":58.02,"profit":true}]
Cost of Revenue	-	11.32%	12.40%	15.07%	10.39%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":75.12,"profit":true},{"date":"2023-03-31","value":82.29,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":68.95,"profit":true}]
Gross Profit	-	11.74%	13.05%	1.76%	5.97%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":89.97,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":13.45,"profit":true},{"date":"2025-03-31","value":45.75,"profit":true}]
Gross Margin	-	0.12%	0.18%	(3.88%)	(1.38%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":65.59,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":-2176.21,"profit":false},{"date":"2025-03-31","value":-773.61,"profit":false}]

Operating Expenses	-	18.12%	14.57%	14.19%	1.55%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":80.38,"profit":true},{"date":"2024-03-31","value":78.27,"profit":true},{"date":"2025-03-31","value":8.55,"profit":true}]
Operating Income	-	(9.51%)	6.44%	(56.36%)	60.03%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-15.84,"profit":false},{"date":"2023-03-31","value":10.72,"profit":true},{"date":"2024-03-31","value":-93.88,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	5.25%	(26.22%)	35.80%	8.72%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":14.68,"profit":true},{"date":"2023-03-31","value":-73.25,"profit":false},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":24.35,"profit":true}]
Pre-Tax Income	-	(17.38%)	23.97%	(85.93%)	231.66%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-7.5,"profit":false},{"date":"2023-03-31","value":10.35,"profit":true},{"date":"2024-03-31","value":-37.09,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Income Taxes	-	(828.71%)	(19.82%)	(257.46%)	(173.23%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":null,"profit":false},{"date":"2023-03-31","value":null,"profit":false},{"date":"2024-03-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false}]
Income After Taxes	-	(38.81%)	37.74%	(54.52%)	(25.00%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-102.84,"profit":false},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":-144.44,"profit":false},{"date":"2025-03-31","value":-66.25,"profit":false}]

Income From Continuous Operations	-	(38.81%)	37.74%	(54.52%)	(25.00%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-102.84,"profit":false},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":-144.44,"profit":false},{"date":"2025-03-31","value":-66.25,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Net Income	-	(38.81%)	37.80%	(54.56%)	(25.08%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-102.69,"profit":false},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":-144.33,"profit":false},{"date":"2025-03-31","value":-66.37,"profit":false}]

EPS (Diluted)	-	(51.07%)	(7.86%)	(13.47%)	(38.18%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":null,"profit":false},{"date":"2023-03-31","value":null,"profit":false},{"date":"2024-03-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false}]

	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	TREND
Total Revenue	1.14T	1.05T	1.11T	1.11T	1.21T	[{"date":"2024-12-31","value":94.31,"profit":true},{"date":"2025-03-31","value":86.83,"profit":true},{"date":"2025-06-30","value":91.22,"profit":true},{"date":"2025-09-30","value":91.72,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Cost of Revenue	416.87B	382.10B	384.68B	380.06B	552.87B	[{"date":"2024-12-31","value":75.4,"profit":true},{"date":"2025-03-31","value":69.11,"profit":true},{"date":"2025-06-30","value":69.58,"profit":true},{"date":"2025-09-30","value":68.74,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Gross Profit	727.25B	671.30B	722.01B	732.74B	660.35B	[{"date":"2024-12-31","value":99.25,"profit":true},{"date":"2025-03-31","value":91.62,"profit":true},{"date":"2025-06-30","value":98.54,"profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":90.12,"profit":true}]
Gross Margin	63.56%	63.73%	65.24%	65.85%	54.43%	[{"date":"2024-12-31","value":96.53,"profit":true},{"date":"2025-03-31","value":96.78,"profit":true},{"date":"2025-06-30","value":99.08,"profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":82.66,"profit":true}]

Operating Expenses	660.31B	746.20B	537.44B	663.74B	466.28B	[{"date":"2024-12-31","value":88.49,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":72.02,"profit":true},{"date":"2025-09-30","value":88.95,"profit":true},{"date":"2025-12-31","value":62.49,"profit":true}]
Operating Income	66.94B	(74.90B)	184.57B	69.00B	194.06B	[{"date":"2024-12-31","value":34.49,"profit":true},{"date":"2025-03-31","value":-38.6,"profit":false},{"date":"2025-06-30","value":95.11,"profit":true},{"date":"2025-09-30","value":35.55,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	(79.12B)	(61.02B)	(67.34B)	(79.56B)	(93.54B)	[{"date":"2024-12-31","value":-7911900000000,"profit":false},{"date":"2025-03-31","value":-6101800000000,"profit":false},{"date":"2025-06-30","value":-6733600000000,"profit":false},{"date":"2025-09-30","value":-7956300000000,"profit":false},{"date":"2025-12-31","value":-9353863300000,"profit":false}]
Pre-Tax Income	26.41B	(107.30B)	150.63B	28.17B	136.28B	[{"date":"2024-12-31","value":17.53,"profit":true},{"date":"2025-03-31","value":-71.23,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":18.7,"profit":true},{"date":"2025-12-31","value":90.47,"profit":true}]
Income Taxes	2.57B	(4.20B)	26.35B	39.90B	30.67B	[{"date":"2024-12-31","value":6.45,"profit":true},{"date":"2025-03-31","value":-10.53,"profit":false},{"date":"2025-06-30","value":66.04,"profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":76.87,"profit":true}]
Income After Taxes	23.84B	(103.10B)	124.28B	(11.73B)	105.61B	[{"date":"2024-12-31","value":19.18,"profit":true},{"date":"2025-03-31","value":-82.96,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-9.44,"profit":false},{"date":"2025-12-31","value":84.97,"profit":true}]

Income From Continuous Operations	23.84B	(103.10B)	124.28B	(11.73B)	103.73B	[{"date":"2024-12-31","value":19.18,"profit":true},{"date":"2025-03-31","value":-82.96,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-9.44,"profit":false},{"date":"2025-12-31","value":83.47,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income	23.79B	(103.20B)	124.24B	(11.80B)	105.51B	[{"date":"2024-12-31","value":19.15,"profit":true},{"date":"2025-03-31","value":-83.06,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-9.5,"profit":false},{"date":"2025-12-31","value":84.92,"profit":true}]

EPS (Diluted)	0.05	(0.23)	151.00	(0.03)	0.21	[{"date":"2024-12-31","value":0.03,"profit":true},{"date":"2025-03-31","value":-0.15,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-0.02,"profit":false},{"date":"2025-12-31","value":0.14,"profit":true}]

	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	TREND
Total Revenue	-	(7.93%)	5.06%	0.55%	9.02%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-87.87,"profit":false},{"date":"2025-06-30","value":56.06,"profit":true},{"date":"2025-09-30","value":6.12,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Cost of Revenue	-	(8.34%)	0.67%	(1.20%)	45.47%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-18.35,"profit":false},{"date":"2025-06-30","value":1.48,"profit":true},{"date":"2025-09-30","value":-2.64,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Gross Profit	-	(7.69%)	7.55%	1.49%	(9.88%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-101.84,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":19.66,"profit":true},{"date":"2025-12-31","value":-130.78,"profit":false}]
Gross Margin	-	0.26%	2.38%	0.93%	(17.34%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":10.8,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":39.07,"profit":true},{"date":"2025-12-31","value":-729.9,"profit":false}]

Operating Expenses	-	13.01%	(27.98%)	23.50%	(29.75%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":55.35,"profit":true},{"date":"2025-06-30","value":-119.05,"profit":false},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":-126.6,"profit":false}]
Operating Income	-	(211.89%)	(346.42%)	(62.62%)	181.27%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-116.89,"profit":false},{"date":"2025-06-30","value":-191.1,"profit":false},{"date":"2025-09-30","value":-34.54,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	(22.88%)	10.35%	18.16%	17.57%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-125.99,"profit":false},{"date":"2025-06-30","value":57.02,"profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":96.74,"profit":true}]
Pre-Tax Income	-	(506.33%)	(240.38%)	(81.30%)	383.71%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-131.96,"profit":false},{"date":"2025-06-30","value":-62.65,"profit":false},{"date":"2025-09-30","value":-21.19,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Income Taxes	-	(263.30%)	(727.40%)	51.43%	(23.13%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-511.96,"profit":false},{"date":"2025-06-30","value":-1414.39,"profit":false},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":-44.97,"profit":false}]
Income After Taxes	-	(532.56%)	(220.54%)	(109.44%)	(1000.38%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false},{"date":"2025-12-31","value":null,"profit":false}]

Income From Continuous Operations	-	(532.55%)	(220.54%)	(109.44%)	(984.41%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false},{"date":"2025-12-31","value":null,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income	-	(533.81%)	(220.39%)	(109.50%)	(994.00%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false},{"date":"2025-12-31","value":null,"profit":false}]

EPS (Diluted)	-	(576.15%)	(66444.46%)	(100.02%)	(929.64%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false},{"date":"2025-12-31","value":null,"profit":false}]

	Mar '21	Mar '22	Mar '23	Mar '24	Mar '25	5YR TREND
Total Assets
Current Assets	2.71T	2.59T	2.40T	2.56T	2.52T	[{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":95.6,"profit":true},{"date":"2023-03-31","value":88.39,"profit":true},{"date":"2024-03-31","value":94.31,"profit":true},{"date":"2025-03-31","value":92.93,"profit":true}]
Non-current Assets	10.20T	10.58T	11.56T	12.55T	11.73T	[{"date":"2021-03-31","value":81.27,"profit":true},{"date":"2022-03-31","value":84.34,"profit":true},{"date":"2023-03-31","value":92.11,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":93.44,"profit":true}]
Total Assets	12.91T	13.18T	13.96T	15.11T	14.25T	[{"date":"2021-03-31","value":85.46,"profit":true},{"date":"2022-03-31","value":87.22,"profit":true},{"date":"2023-03-31","value":92.38,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":94.3,"profit":true}]

Total Liabilities
Current Liabilities	1.77T	2.15T	2.48T	2.31T	2.51T	[{"date":"2021-03-31","value":70.74,"profit":true},{"date":"2022-03-31","value":85.61,"profit":true},{"date":"2023-03-31","value":99.02,"profit":true},{"date":"2024-03-31","value":92.28,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Non-current Liabilities	5.96T	5.35T	5.12T	5.52T	4.81T	[{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":89.72,"profit":true},{"date":"2023-03-31","value":85.9,"profit":true},{"date":"2024-03-31","value":92.62,"profit":true},{"date":"2025-03-31","value":80.61,"profit":true}]
Total Liabilities	7.74T	7.49T	7.60T	7.83T	7.31T	[{"date":"2021-03-31","value":98.73,"profit":true},{"date":"2022-03-31","value":95.66,"profit":true},{"date":"2023-03-31","value":97.04,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":93.33,"profit":true}]

Total Shareholders' equity
Common Stock	1.67T	1.68T	1.68T	1.68T	1.69T	[{"date":"2021-03-31","value":98.43,"profit":true},{"date":"2022-03-31","value":98.91,"profit":true},{"date":"2023-03-31","value":98.92,"profit":true},{"date":"2024-03-31","value":98.93,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Retained Earnings	1.51T	1.48T	1.54T	1.39T	1.19T	[{"date":"2021-03-31","value":97.97,"profit":true},{"date":"2022-03-31","value":96.01,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":90.27,"profit":true},{"date":"2025-03-31","value":77.06,"profit":true}]
Other Stockholders' Equity	1.63T	1.59T	1.63T	1.70T	1.70T	[{"date":"2021-03-31","value":95.77,"profit":true},{"date":"2022-03-31","value":93.65,"profit":true},{"date":"2023-03-31","value":95.74,"profit":true},{"date":"2024-03-31","value":99.72,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Total Shareholders' equity	5.17T	5.68T	6.35T	7.27T	6.94T	[{"date":"2021-03-31","value":71.12,"profit":true},{"date":"2022-03-31","value":78.14,"profit":true},{"date":"2023-03-31","value":87.36,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":95.35,"profit":true}]

Total Liabilities & Shareholders Equity	12.91T	13.18T	13.96T	15.11T	14.25T	[{"date":"2021-03-31","value":85.44,"profit":true},{"date":"2022-03-31","value":87.22,"profit":true},{"date":"2023-03-31","value":92.38,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":94.3,"profit":true}]

	Mar '21	Mar '22	Mar '23	Mar '24	Mar '25	5YR TREND
Total Assets
Current Assets	-	(4.40%)	(7.54%)	6.70%	(1.46%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-65.62,"profit":false},{"date":"2023-03-31","value":-112.64,"profit":false},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-21.82,"profit":false}]
Non-current Assets	-	3.77%	9.22%	8.57%	(6.56%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":40.96,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":92.97,"profit":true},{"date":"2025-03-31","value":-71.16,"profit":false}]
Total Assets	-	2.06%	5.92%	8.25%	(5.70%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":24.95,"profit":true},{"date":"2023-03-31","value":71.75,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-69.06,"profit":false}]

Total Liabilities
Current Liabilities	-	21.01%	15.67%	(6.80%)	8.36%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":74.58,"profit":true},{"date":"2024-03-31","value":-32.38,"profit":false},{"date":"2025-03-31","value":39.8,"profit":true}]
Non-current Liabilities	-	(10.28%)	(4.26%)	7.82%	(12.96%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-131.5,"profit":false},{"date":"2023-03-31","value":-54.41,"profit":false},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-165.75,"profit":false}]
Total Liabilities	-	(3.11%)	1.45%	3.05%	(6.67%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-102.07,"profit":false},{"date":"2023-03-31","value":47.54,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-218.8,"profit":false}]

Total Shareholders' equity
Common Stock	-	0.49%	0.00%	0.01%	1.08%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":45.11,"profit":true},{"date":"2023-03-31","value":0.45,"profit":true},{"date":"2024-03-31","value":1.39,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Retained Earnings	-	(2.00%)	4.15%	(9.73%)	(14.64%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-48.16,"profit":false},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":-234.36,"profit":false},{"date":"2025-03-31","value":-352.55,"profit":false}]
Other Stockholders' Equity	-	(2.21%)	2.24%	4.15%	0.28%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-53.22,"profit":false},{"date":"2023-03-31","value":53.87,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":6.73,"profit":true}]
Total Shareholders' equity	-	9.86%	11.81%	14.47%	(4.65%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":68.15,"profit":true},{"date":"2023-03-31","value":81.64,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-32.14,"profit":false}]

Total Liabilities & Shareholders Equity	-	2.09%	5.92%	8.25%	(5.70%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":25.31,"profit":true},{"date":"2023-03-31","value":71.76,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-69.08,"profit":false}]

	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	TREND
Total Assets
Current Assets	2.75T	2.52T	2.51T	2.92T	3.12T	[{"date":"2024-12-31","value":88.32,"profit":true},{"date":"2025-03-31","value":80.84,"profit":true},{"date":"2025-06-30","value":80.59,"profit":true},{"date":"2025-09-30","value":93.65,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Non-current Assets	12.35T	11.73T	11.49T	11.55T	12.30T	[{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":94.94,"profit":true},{"date":"2025-06-30","value":93.03,"profit":true},{"date":"2025-09-30","value":93.5,"profit":true},{"date":"2025-12-31","value":99.58,"profit":true}]
Total Assets	15.11T	14.25T	14.00T	14.47T	15.42T	[{"date":"2024-12-31","value":97.97,"profit":true},{"date":"2025-03-31","value":92.41,"profit":true},{"date":"2025-06-30","value":90.82,"profit":true},{"date":"2025-09-30","value":93.85,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	2.10T	2.51T	2.17T	2.14T	2.61T	[{"date":"2024-12-31","value":80.32,"profit":true},{"date":"2025-03-31","value":95.96,"profit":true},{"date":"2025-06-30","value":83.06,"profit":true},{"date":"2025-09-30","value":81.92,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Non-current Liabilities	5.59T	4.81T	4.97T	5.20T	5.16T	[{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":85.98,"profit":true},{"date":"2025-06-30","value":88.89,"profit":true},{"date":"2025-09-30","value":93.01,"profit":true},{"date":"2025-12-31","value":92.28,"profit":true}]
Total Liabilities	7.69T	7.31T	7.14T	7.34T	7.77T	[{"date":"2024-12-31","value":98.94,"profit":true},{"date":"2025-03-31","value":94.11,"profit":true},{"date":"2025-06-30","value":91.87,"profit":true},{"date":"2025-09-30","value":94.45,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	1.69T	1.69T	1.69T	1.69T	1.70T	[{"date":"2024-12-31","value":99.93,"profit":true},{"date":"2025-03-31","value":99.93,"profit":true},{"date":"2025-06-30","value":99.93,"profit":true},{"date":"2025-09-30","value":99.93,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Retained Earnings	1.29T	1.19T	1.16T	1.15T	1.10T	[{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":91.99,"profit":true},{"date":"2025-06-30","value":89.6,"profit":true},{"date":"2025-09-30","value":88.98,"profit":true},{"date":"2025-12-31","value":84.93,"profit":true}]
Other Stockholders' Equity	1.73T	1.70T	1.67T	4.29T	1.70T	[{"date":"2024-12-31","value":40.35,"profit":true},{"date":"2025-03-31","value":39.64,"profit":true},{"date":"2025-06-30","value":38.84,"profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":39.71,"profit":true}]
Total Shareholders' equity	7.42T	6.94T	6.87T	7.13T	7.65T	[{"date":"2024-12-31","value":96.99,"profit":true},{"date":"2025-03-31","value":90.68,"profit":true},{"date":"2025-06-30","value":89.76,"profit":true},{"date":"2025-09-30","value":93.23,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	15.11T	14.25T	14.00T	14.47T	15.42T	[{"date":"2024-12-31","value":97.98,"profit":true},{"date":"2025-03-31","value":92.41,"profit":true},{"date":"2025-06-30","value":90.83,"profit":true},{"date":"2025-09-30","value":93.85,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	TREND
Total Assets
Current Assets	-	(8.46%)	(0.32%)	16.21%	6.78%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-52.19,"profit":false},{"date":"2025-06-30","value":-1.97,"profit":false},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":41.8,"profit":true}]
Non-current Assets	-	(5.06%)	(2.01%)	0.51%	6.50%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-77.86,"profit":false},{"date":"2025-06-30","value":-30.91,"profit":false},{"date":"2025-09-30","value":7.8,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Total Assets	-	(5.68%)	(1.71%)	3.33%	6.56%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-86.65,"profit":false},{"date":"2025-06-30","value":-26.09,"profit":false},{"date":"2025-09-30","value":50.71,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	19.47%	(13.44%)	(1.38%)	22.07%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":88.22,"profit":true},{"date":"2025-06-30","value":-60.9,"profit":false},{"date":"2025-09-30","value":-6.25,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Non-current Liabilities	-	(14.02%)	3.39%	4.63%	(0.79%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-302.7,"profit":false},{"date":"2025-06-30","value":73.18,"profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":-17,"profit":false}]
Total Liabilities	-	(4.88%)	(2.38%)	2.81%	5.88%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-83.05,"profit":false},{"date":"2025-06-30","value":-40.48,"profit":false},{"date":"2025-09-30","value":47.72,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	0.00%	0.00%	0.00%	0.07%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":2.15,"profit":true},{"date":"2025-06-30","value":2.24,"profit":true},{"date":"2025-09-30","value":4.13,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Retained Earnings	-	(8.01%)	(2.60%)	(0.69%)	(4.55%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false},{"date":"2025-12-31","value":null,"profit":false}]
Other Stockholders' Equity	-	(1.75%)	(2.03%)	157.50%	(60.29%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-1.11,"profit":false},{"date":"2025-06-30","value":-1.29,"profit":false},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":-38.28,"profit":false}]
Total Shareholders' equity	-	(6.51%)	(1.01%)	3.87%	7.26%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-89.76,"profit":false},{"date":"2025-06-30","value":-13.87,"profit":false},{"date":"2025-09-30","value":53.28,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	(5.68%)	(1.71%)	3.33%	6.56%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-86.66,"profit":false},{"date":"2025-06-30","value":-26.1,"profit":false},{"date":"2025-09-30","value":50.71,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

	Mar '21	Mar '22	Mar '23	Mar '24	Mar '25	5YR TREND
Operating Activities
Net Operating Cash Flow	1.01T	1.12T	977.16B	716.34B	1.06T	[{"date":"2021-03-31","value":90.01,"profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":87,"profit":true},{"date":"2024-03-31","value":63.78,"profit":true},{"date":"2025-03-31","value":94.13,"profit":true}]

Investing Activities
Net Investing Cash Flow	393.53B	(198.13B)	(607.10B)	(463.86B)	(367.06B)	[{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":-50.35,"profit":false},{"date":"2023-03-31","value":-154.27,"profit":false},{"date":"2024-03-31","value":-117.87,"profit":false},{"date":"2025-03-31","value":-93.27,"profit":false}]

Financing Activities
Net Financing Cash Flow	(1.09T)	(1.07T)	(709.15B)	(354.42B)	(751.42B)	[{"date":"2021-03-31","value":-108835400000000,"profit":false},{"date":"2022-03-31","value":-107026500000000,"profit":false},{"date":"2023-03-31","value":-70914800000000,"profit":false},{"date":"2024-03-31","value":-35441600000000,"profit":false},{"date":"2025-03-31","value":-75142500000000,"profit":false}]

Net Change in Cash	328.61B	(116.53B)	(316.17B)	(75.73B)	(72.69B)	[{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":-35.46,"profit":false},{"date":"2023-03-31","value":-96.21,"profit":false},{"date":"2024-03-31","value":-23.05,"profit":false},{"date":"2025-03-31","value":-22.12,"profit":false}]

Free Cash Flow
Free Cash Flow	774.46B	937.07B	343.47B	235.61B	856.39B	[{"date":"2021-03-31","value":82.65,"profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":36.65,"profit":true},{"date":"2024-03-31","value":25.14,"profit":true},{"date":"2025-03-31","value":91.39,"profit":true}]

	Mar '21	Mar '22	Mar '23	Mar '24	Mar '25	5YR TREND
Operating Activities
Net Operating Cash Flow	-	11.10%	(13.00%)	(26.69%)	47.58%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":23.32,"profit":true},{"date":"2023-03-31","value":-27.31,"profit":false},{"date":"2024-03-31","value":-56.1,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(150.35%)	206.42%	(23.59%)	(20.87%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-72.83,"profit":false},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":-11.43,"profit":false},{"date":"2025-03-31","value":-10.11,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(1.66%)	(33.74%)	(50.02%)	112.02%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-1.48,"profit":false},{"date":"2023-03-31","value":-30.12,"profit":false},{"date":"2024-03-31","value":-44.66,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

Net Change in Cash	-	(135.46%)	171.32%	(76.05%)	(4.02%)	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-79.07,"profit":false},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":-44.39,"profit":false},{"date":"2025-03-31","value":-2.35,"profit":false}]

Free Cash Flow
Free Cash Flow	-	21.00%	(63.35%)	(31.40%)	263.47%	[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":7.97,"profit":true},{"date":"2023-03-31","value":-24.04,"profit":false},{"date":"2024-03-31","value":-11.92,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	TREND
Operating Activities
Net Operating Cash Flow	383.76B	222.16B	215.42B	378.23B	360.04B	[{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":57.89,"profit":true},{"date":"2025-06-30","value":56.14,"profit":true},{"date":"2025-09-30","value":98.56,"profit":true},{"date":"2025-12-31","value":93.82,"profit":true}]

Investing Activities
Net Investing Cash Flow	(115.56B)	(19.68B)	(33.19B)	(48.13B)	(247.98B)	[{"date":"2024-12-31","value":-11555500000000,"profit":false},{"date":"2025-03-31","value":-1968100000000,"profit":false},{"date":"2025-06-30","value":-3319300000000,"profit":false},{"date":"2025-09-30","value":-4813300000000,"profit":false},{"date":"2025-12-31","value":-24797589400000,"profit":false}]

Financing Activities
Net Financing Cash Flow	(655.97B)	(301.79B)	(214.90B)	(11.98B)	(169.51B)	[{"date":"2024-12-31","value":-65596900000000,"profit":false},{"date":"2025-03-31","value":-30179200000000,"profit":false},{"date":"2025-06-30","value":-21490000000000,"profit":false},{"date":"2025-09-30","value":-1198100000000,"profit":false},{"date":"2025-12-31","value":-16950693800000,"profit":false}]

Net Change in Cash	(364.89B)	(109.01B)	(35.10B)	331.48B	(68.40B)	[{"date":"2024-12-31","value":-110.08,"profit":false},{"date":"2025-03-31","value":-32.89,"profit":false},{"date":"2025-06-30","value":-10.59,"profit":false},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":-20.64,"profit":false}]

Free Cash Flow
Free Cash Flow	338.67B	173.37B	140.35B	325.40B	317.47B	[{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":51.19,"profit":true},{"date":"2025-06-30","value":41.44,"profit":true},{"date":"2025-09-30","value":96.08,"profit":true},{"date":"2025-12-31","value":93.74,"profit":true}]

	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	TREND
Operating Activities
Net Operating Cash Flow	-	(42.11%)	(3.03%)	75.57%	(4.81%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-55.72,"profit":false},{"date":"2025-06-30","value":-4.01,"profit":false},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":-6.36,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(82.97%)	68.66%	45.01%	415.19%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-19.98,"profit":false},{"date":"2025-06-30","value":16.54,"profit":true},{"date":"2025-09-30","value":10.84,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	(53.99%)	(28.79%)	(94.42%)	1314.80%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-4.11,"profit":false},{"date":"2025-06-30","value":-2.19,"profit":false},{"date":"2025-09-30","value":-7.18,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]

Net Change in Cash	-	(70.12%)	(67.80%)	(1044.25%)	(120.64%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false},{"date":"2025-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(48.81%)	(19.04%)	131.84%	(2.44%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-37.02,"profit":false},{"date":"2025-06-30","value":-14.44,"profit":false},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":-1.85,"profit":false}]

Takeda Pharmaceutical Co Ltd ADR Ratios

Takeda Pharmaceutical Co Ltd ADR Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	TAK
Cash Ratio	0.29
Current Ratio	1.19
Quick Ratio	0.65

Takeda Pharmaceutical Co Ltd ADR Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	TAK
ROA (LTM)	2.47%
ROE (LTM)	1.50%

Takeda Pharmaceutical Co Ltd ADR Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	TAK
Debt Ratio Lower is generally better. Negative is bad.	0.50
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.50

Takeda Pharmaceutical Co Ltd ADR Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	TAK
Trailing PE	79.39
Forward PE	12.77
P/S (TTM)	0.01
P/B	1.17
Price/FCF	0
EV/R	2.90
EV/Ebitda	10.42
PEG	0.40

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Takeda Pharmaceutical Co Ltd ADR share price today?

Takeda Pharmaceutical Co Ltd ADR (TAK) share price today is $18.54

Can Indians buy Takeda Pharmaceutical Co Ltd ADR shares?

Yes, Indians can buy shares of Takeda Pharmaceutical Co Ltd ADR (TAK) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TAK stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Takeda Pharmaceutical Co Ltd ADR be purchased?

Yes, you can purchase fractional shares of Takeda Pharmaceutical Co Ltd ADR (TAK) via the Vested app. You can start investing in Takeda Pharmaceutical Co Ltd ADR (TAK) with a minimum investment of $1.

How to invest in Takeda Pharmaceutical Co Ltd ADR shares from India?

You can invest in shares of Takeda Pharmaceutical Co Ltd ADR (TAK) via Vested in three simple steps:

Click on Sign Up or Invest in TAK stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Takeda Pharmaceutical Co Ltd ADR shares

What is Takeda Pharmaceutical Co Ltd ADR 52-week high and low stock price?

The 52-week high price of Takeda Pharmaceutical Co Ltd ADR (TAK) is $18.5. The 52-week low price of Takeda Pharmaceutical Co Ltd ADR (TAK) is $12.99.

What is Takeda Pharmaceutical Co Ltd ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Takeda Pharmaceutical Co Ltd ADR (TAK) is 79.3913

What is Takeda Pharmaceutical Co Ltd ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Takeda Pharmaceutical Co Ltd ADR (TAK) is 1.17

What is Takeda Pharmaceutical Co Ltd ADR dividend yield?

The dividend yield of Takeda Pharmaceutical Co Ltd ADR (TAK) is 3.58%

What is the Market Cap of Takeda Pharmaceutical Co Ltd ADR?

The market capitalization of Takeda Pharmaceutical Co Ltd ADR (TAK) is $57.69B

What is Takeda Pharmaceutical Co Ltd ADR's stock symbol?

The stock symbol (or ticker) of Takeda Pharmaceutical Co Ltd ADR is TAK

How Can Investors Use Takeda Pharmaceutical Co Ltd ADR Share Price Data for Long-Term Investment Decisions?

Consider the share price of Takeda Pharmaceutical Co Ltd ADR as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Takeda Pharmaceutical Co Ltd ADR has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Takeda Pharmaceutical Co Ltd ADR shares for Indian investors?

When investing in Takeda Pharmaceutical Co Ltd ADR shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Takeda Pharmaceutical Co Ltd ADR stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Takeda Pharmaceutical Co Ltd ADR share price with other stocks in the same sector?

Rather than merely checking the share price of Takeda Pharmaceutical Co Ltd ADR and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Takeda Pharmaceutical Co Ltd ADR stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Takeda Pharmaceutical Co Ltd ADR Share Price

Takeda Pharmaceutical Co Ltd ADR Analyst Forecast

Takeda Pharmaceutical Co Ltd ADR Share Price Chart

Takeda Pharmaceutical Co Ltd ADR Key Stock Metrics

About Takeda Pharmaceutical Co Ltd ADR, Common Stock

Takeda Pharmaceutical Co Ltd ADR Stock Returns

Takeda Pharmaceutical Co Ltd ADR Financials

Takeda Pharmaceutical Co Ltd ADR Ratios

Takeda Pharmaceutical Co Ltd ADR Liquidity Ratios

Takeda Pharmaceutical Co Ltd ADR Asset Efficiency Ratios

Takeda Pharmaceutical Co Ltd ADR Liability Ratios

Takeda Pharmaceutical Co Ltd ADR Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Takeda Pharmaceutical Co Ltd ADR Share Price

Takeda Pharmaceutical Co Ltd ADR Analyst Forecast

Takeda Pharmaceutical Co Ltd ADR Share Price Chart

Takeda Pharmaceutical Co Ltd ADR Key Stock Metrics

About Takeda Pharmaceutical Co Ltd ADR, Common Stock

Takeda Pharmaceutical Co Ltd ADR Stock Returns

Takeda Pharmaceutical Co Ltd ADR Financials

Takeda Pharmaceutical Co Ltd ADR Ratios

Takeda Pharmaceutical Co Ltd ADR Liquidity Ratios

Takeda Pharmaceutical Co Ltd ADR Asset Efficiency Ratios

Takeda Pharmaceutical Co Ltd ADR Liability Ratios

Takeda Pharmaceutical Co Ltd ADR Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²